 |
|
Lack of sleep could be more dangerous for women than men
July 02, 2009Women who get less than the recommended eight hours sleep a night are at higher risk of heart disease and heart-related problems than men with the same sleeping patterns.
Research by the University of Warwick and University College London has found that levels of inflammatory markers vary significantly with sleep duration in women, but not men.
The study, published today (Weds) in the American journal SLEEP, found levels of Interleukin-6 (IL-6), a marker related to coronary heart disease, were significantly lower in women who reported sleeping eight hours as compared with 7hours.
A second marker, High-sensitivity C-reactive protein (hs-CRP), is predictive of future cardiovascular morbidity. Levels of hs-CRP were significantly higher in women who reported sleeping five hours or less.
Lead author of the study, Associate Professor of Biochemical Medicine at Warwick Medical School Michelle Miller said short-term sleep deprivation studies have shown that inflammatory markers are elevated in sleep-deprived individuals, suggesting that inflammatory mechanisms may play a role in the cardiovascular risk associated with sleep deprivation.
She said: "Our study may provide some insight into a potential mechanism for the observation in previous studies which indicates an increased risk of death from cardiovascular disease in individuals who have less than five hours sleep per night and increased risk of non-cardiovascular death in long sleepers."
This is the first large-scale study to describe the associations between measures of inflammation and sleep duration in both men and women. The study involved more than 4,600 white participants from the University College London-based Whitehall II cohort study; 73% were men. Participants between the ages of 35 and 55 years were recruited between 1985 and 1988 from 20 London-based civil service departments. Data for this study is from the phase 3 follow-up (1991-1993). Sleep duration was determined by subjective questionnaires, and general health was assessed during a screening examination.
Dr Miller added: "These findings add to the growing body of evidence which suggests that there is a non-linear relationship between cardiovascular risk factors and duration of sleep. Furthermore, they support the idea that short sleep is associated with an increase in cardiovascular risk and that the association between sleep duration and cardiovascular risk factors is markedly different in men and women.
"Further prospective studies are required to ascertain causality but the results also are consistent with the idea that sleeping seven or eight hours per night appears to be optimal for health."
University of Warwick
A second marker, High-sensitivity C-reactive protein (hs-CRP), is predictive of future cardiovascular morbidity. Levels of hs-CRP were significantly higher in women who reported sleeping five hours or less.
Lead author of the study, Associate Professor of Biochemical Medicine at Warwick Medical School Michelle Miller said short-term sleep deprivation studies have shown that inflammatory markers are elevated in sleep-deprived individuals, suggesting that inflammatory mechanisms may play a role in the cardiovascular risk associated with sleep deprivation.
She said: "Our study may provide some insight into a potential mechanism for the observation in previous studies which indicates an increased risk of death from cardiovascular disease in individuals who have less than five hours sleep per night and increased risk of non-cardiovascular death in long sleepers."
This is the first large-scale study to describe the associations between measures of inflammation and sleep duration in both men and women. The study involved more than 4,600 white participants from the University College London-based Whitehall II cohort study; 73% were men. Participants between the ages of 35 and 55 years were recruited between 1985 and 1988 from 20 London-based civil service departments. Data for this study is from the phase 3 follow-up (1991-1993). Sleep duration was determined by subjective questionnaires, and general health was assessed during a screening examination.
Dr Miller added: "These findings add to the growing body of evidence which suggests that there is a non-linear relationship between cardiovascular risk factors and duration of sleep. Furthermore, they support the idea that short sleep is associated with an increase in cardiovascular risk and that the association between sleep duration and cardiovascular risk factors is markedly different in men and women.
"Further prospective studies are required to ascertain causality but the results also are consistent with the idea that sleeping seven or eight hours per night appears to be optimal for health."
University of Warwick
Cardiovascular Risk Current Events and Cardiovascular Risk News RSSNight Beat, Overtime and a Disrupted Sleep Pattern Can Harm Officers' Health
A police officer who works the night shift, typically from 8 p.m. to 4 a.m., already is at a disadvantage when it comes to getting a good "night's" sleep.
A decade later, lifestyle changes or metformin still lower type 2 diabetes risk
Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent compared with placebo in people at high risk for the disease, researchers conclude based on 10 years of data.
Research: Migraine and cardiovascular disease: Systematic review and meta-analysis
Migraine with aura (temporary visual or sensory disturbances before or during a migraine headache) is associated with a twofold increased risk of stroke, finds a study published on bmj.com today.
Web-based nutrition program reduces health care costs for employees with cardiac risk factors
Researchers from Boston University School of Medicine (BUSM) and Boston University School of Public Health (BUSPH) have shown that an employer-sponsored, internet-based diet and exercise program shows promise as a low-cost benefit to lower healthcare costs for those at higher risk for above-average costs and healthcare utilization such as cardiac, hyperlipidemia, hypertension or diabetes patients. These findings appear in the current issue of the Journal of Medical Internet Research.
Experts unveil new CVD guidelines and position papers
Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week.
Puberty a gateway to heart disease for Canada's teens
A seven-year ongoing study examining over 20,000 Canadian grade 9 students shows most already have at least one major risk factor for heart disease and stroke, Dr. Brian McCrindle told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
Obesity may hinder optimal control of blood pressure and cholesterol
Obese patients taking medications to lower their blood pressure and cholesterol levels are less likely to reach recommended targets for these cardiovascular disease risk factors than their normal weight counterparts, according to new research presented at the 2009 Canadian Cardiovascular Congress hosted by the Canadian Cardiovascular Society and the Heart and Stroke Foundation of Canada.
Lupus patients perceive benefit from cardiovascular disease prevention counseling program
According to a new study by Hospital for Special Surgery investigators presented at the American College of Rheumatology meeting on October 21 in Philadelphia, most lupus patients are not aware that their condition puts them at a higher risk for cardiovascular disease and a counseling program is a valuable way to promote education and lifestyle change.
Improved diet and exercise alone unlikely to cure obstructive sleep apnea in obese patients
A study in the Oct. 15 issue of the Journal of Clinical Sleep Medicine found that while a strict diet and exercise program may benefit obese patients with mild to moderate obstructive sleep apnea (OSA), it is unlikely to eliminate the condition.
Suppressing a gene in mice prevents heart from aging, preserves its function
Scientists prevented age-related changes in the hearts of mice and preserved heart function by suppressing a form of the PI3K gene, in a study reported in Circulation: Journal of the American Heart Association.
More Cardiovascular Risk Current Events and Cardiovascular Risk News Articles
 |
Clinical Manual of Total Cardiovascular Risk by Neil R. Poulter (Author) The etiology of coronary heart disease and stroke has been known for decades to be multifactorial - an increasing risk of both CHD and stroke has been shown to have a graded continuous relationship with rising BP and total cholesterol across the whole BP and cholesterol ranges. The coexistance of other risk factors, such as smoking, obesity and age, has been shown to result in a dramatically increased risk. Alongside the numerous risk factors themselves, there is an ever increasing number of papers published aiming to stratify the risk factors. With an also increasing number of guidelines published, there is the need to simplify all of these data into a simple manual. "Clinician's Manual of Total Cardiovascular Risk" provides rapid answers to common clinical questions relating to... |
 |
Reducing The Risk Of Cardiovascular Disease Dr. Andrew Weil (Primary Contributor) |
|
Managing Your Cardiovascular Risk Factors (Mayo Clinic Patient Education) Closed Captioned DVD. | |
 |
Best Cardiovascular Support - 60 Vcaps., (Doctor's Best) by HerbalLoveShop Science-Based Nutrition Featuring Flavoxine Helps Maintain Cholesterol Levels Already in the Normal Range Enhances Cardiovascular Function Dietary Supplement Flavoxine is a new, all natural patented proprietary combination of extracts from Citrus and Phellodendron amurense. Animal studies have shown that the ingredients in Flavoxine possess beneficial effects on heart function and support the maintenance of healthy levels of cholesterol. Supplementation with Flavoxine in a double-blind, placebo-controlled human clinical trial also resulted in significant benefits to cardiovascular health and cholesterol maintenance. Helps Maintain Cholesterol Levels Already in the Normal Range Promotes Healthy Heart Function |
 |
Clinical Management of Cardiovascular Risk Factors in Diabetes by Moser Marvin (Author), James R. Sowers (Author) Presents the rationale for why physicians should more aggressively treat hypertension and other CV risk factors in their diabetic patients. Specific therapeutic regimens for reducing CV events in diabetic patients are presented, including BP lowering, management of lipid abnormalities, antiplatelet therapy, and glucose control. |
|
Cardiovascular Risk Abstracts by Euromed Communications | |
 |
Cardiovascular Risk Management by Richard Hobbs (Author), Bruce Arroll (Author) Practical ABC style Enables doctors to prioritise treatment using risk-scoring systems and holistic recommendations for reducing cardiovascular risk Includes treatment plans for individuals with diabetes, who are at high risk of developing cardiovascular disease How to reduce cardiovascular risk in other specific patient groups Developed by expert groups in different regions of the world |
|
National Guidelines and Tools for Cardiovascular Risk Reduction: A Pocket Guide by Mary Ann Champagne (Author) | |
|
National Guidelines and Tools for Cardiovascular Risk Reduction by Pcna (Author) | |
 |
Atherosclerosis, Large Arteries and Cardiovascular Risk (Advances in Cardiology) by Michel E. Safar (Editor), Edward D. Frohlich (Editor) This book presents the current thinking of international experts regarding the underlying mechanisms of cardiovascular risk as well as the pathogenesis and pathophysiology of impaired large arterial stiffness and reduced large arterial distensibility. It also demonstrates the rationale for the present approach to the management and treatment of hypertensive diseases and atherosclerosis. The targeted readership includes basic scientists in vascular physiology as well as physicians and scientists in cardiovascular medicine, diabetes mellitus and renal diseases. |
| © 2009 BrightSurf.com |